IntelGenx Technologies (IGX) News Today → Exposed: 10 CENT Crypto to Explode May 20th? (From True Market Insiders) (Ad) Free IGX Stock Alerts C$0.58 +0.01 (+1.75%) (As of 10/6/2021) Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 28 at 12:37 PM | finanznachrichten.deIntelGenx Technologies Corp.: IntelGenx Obtains Court-Approval of a Sale and Investment Solicitation ProcessMay 17, 2024 | finanznachrichten.deIntelGenx Technologies Corp.: IntelGenx Initiates Restructuring Proceedings Under the CCAA to Implement a Review of its Strategic AlternativesMay 17, 2024 | theglobeandmail.comClosing Bell: Intelgenx Technologies Corp up on Thursday (IGX)May 15, 2024 | washingtonpost.comIntelGenx: Q1 Earnings SnapshotApril 8, 2024 | ca.finance.yahoo.comStocks in play: IntelGenx Corp.April 5, 2024 | finanznachrichten.deIntelGenx Technologies Corp.: IntelGenx Updates Status of Buprenorphine Buccal Film ANDAFebruary 20, 2024 | uk.finance.yahoo.comIntelGenx Launches Preferred Share Regulation A OfferingJanuary 11, 2024 | msn.comNVIDIA partners with Amgen to build generative AI models for drug discoveryJanuary 2, 2024 | finance.yahoo.comCHANGES TO BOARD OF DIRECTORS OF GEEKCODecember 18, 2023 | finanznachrichten.deIntelGenx Technologies Corp.: IntelGenx Announces New Animal Health Partnership; Enters into Development and License Agreements for VetaFilmDecember 5, 2023 | finance.yahoo.comIntelGenx Announces Closing of Previously Announced Subsequent Non-Brokered Private Placement With atai Life Sciences for Aggregate Gross Proceeds of US$750,000December 4, 2023 | finance.yahoo.comIntelGenx Announces Changes to its Board of DirectorsNovember 29, 2023 | finanznachrichten.deIntelGenx Technologies Corp.: IntelGenx Announces Shareholder Approval of Financing TransactionsNovember 13, 2023 | theglobeandmail.comClosing Bell: Intelgenx Technologies Corp up on Monday (IGX)November 10, 2023 | finanznachrichten.deIntelGenx Technologies Corp.: IntelGenx Reports Third Quarter 2023 Financial ResultsNovember 7, 2023 | theglobeandmail.comClosing Bell: Intelgenx Technologies Corp up on Tuesday (IGX)November 2, 2023 | finance.yahoo.comIntelGenx to Report Third Quarter 2023 Financial Results on November 9, 2023 – Conference Call to FollowOctober 21, 2023 | theglobeandmail.comClosing Bell: Intelgenx Technologies Corp flat on Friday (IGX)October 13, 2023 | theglobeandmail.comClosing Bell: Intelgenx Technologies Corp down on Thursday (IGX)October 7, 2023 | theglobeandmail.comClosing Bell: Intelgenx Technologies Corp flat on Thursday (IGX)September 19, 2023 | finance.yahoo.comIntelGenx Provides Regulatory Update for Xiromed-Partnered Development Candidate, Buprenorphine Buccal FilmAugust 2, 2023 | msn.comIntelGenx Technologies (IGXT) Price Target Increased by 8.03% to 0.79July 25, 2023 | finanznachrichten.deIntelGenx Technologies Corp.: IntelGenx Announces a Change to its Board of DirectorsJuly 25, 2023 | finance.yahoo.comIntelGenx Provides Update on Research Collaboration Evaluating Montelukast VersaFilm® for the Treatment of Parkinson’s DiseaseMay 31, 2023 | finance.yahoo.comIntelGenx Unveils Short-Term Commercial ObjectivesMay 11, 2023 | marketwatch.com8-K: IntelGenx Technologies Corp.April 27, 2023 | finance.yahoo.comIntelGenx Extends Period to Exercise Certain WarrantsApril 27, 2023 | finance.yahoo.comIntelGenx Announces Receipt of Complete Response Letter from the FDA for Xiromed-Partnered Buprenorphine Buccal FilmApril 20, 2023 | theglobeandmail.comClosing Bell: Intelgenx Technologies Corp up on Wednesday (IGX)April 17, 2023 | theglobeandmail.comClosing Bell: Intelgenx Technologies Corp down on Monday (IGX)April 15, 2023 | theglobeandmail.comClosing Bell: Intelgenx Technologies Corp up on Friday (IGX)April 13, 2023 | finance.yahoo.comIntelGenx Announces Organizational Changes to Support Global Growth StrategyApril 9, 2023 | theglobeandmail.comClosing Bell: Intelgenx Technologies Corp WT flat on Thursday (IGX-WT)March 29, 2023 | finance.yahoo.comIntelGenx Reports Fourth Quarter and Full-Year 2022 Financial ResultsMarch 24, 2023 | finance.yahoo.comIntelGenx Revises Fourth Quarter and Full Year 2022 Financial Results Reporting and Conference Call Date to March 29, 2023March 23, 2023 | finance.yahoo.comIntelGenx to Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023 – Conference Call to FollowMarch 9, 2023 | finance.yahoo.comIntelGenx to Participate in the 35th Annual Roth ConferenceMarch 9, 2023 | finance.yahoo.comCORRECTION – IntelGenx to Participate in the 35th Annual Roth ConferenceFebruary 16, 2023 | ca.finance.yahoo.comIntelGenx Technologies Corp. (IGX.TO)February 13, 2023 | finance.yahoo.comIIROC Trading Halt - IGX.WTJanuary 15, 2023 | msn.comIntelgenx Technologies, Cybin Among Top Psychedelic Movers Of TodayJanuary 9, 2023 | finance.yahoo.comIntelGenx Receives Fourth and Final Loan Tranche from ataiNovember 10, 2022 | finance.yahoo.comIntelGenx Reports Third Quarter 2022 Financial ResultsNovember 9, 2022 | finance.yahoo.comIntelGenx Enters into Feasibility & Development Agreement For CBD-Infused VetaFilm™October 20, 2022 | finance.yahoo.comIntelGenx Announces Issuance of New U.S. Patent Covering VersaFilm® TechnologyOctober 18, 2022 | finance.yahoo.comIntelGenx Submits Response to CRL from FDA for RIZAPORT® VersaFilm®September 20, 2022 | it.tmcnet.comNVIDIA Launches IGX Edge AI Computing Platform for Safe, Secure Autonomous SystemsSeptember 8, 2022 | finance.yahoo.comIntelGenx Announces Enrollment Reaches Halfway Mark in ‘BUENA’ Montelukast VersaFilm® Phase 2a Clinical Trial in Patients with Mild to Moderate Alzheimer’s DiseaseAugust 11, 2022 | finance.yahoo.comIntelGenx Reports Second Quarter 2022 Financial ResultsAugust 4, 2022 | ca.finance.yahoo.comStocks in play: IntelGenx Technologies Corp. Get IntelGenx Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for IGX and its competitors with MarketBeat's FREE daily newsletter. Email Address Must-See: Elon’s New Invention is Absolutely Insane (Ad)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone. Click here for the full story… IGX Media Mentions By Week IGX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IGX News Sentiment▼0.000.80▲Average Medical News Sentiment IGX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IGX Articles This Week▼10▲IGX Articles Average Week Get IntelGenx Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for IGX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Theratechnologies News Sernova News Oncolytics Biotech News ProMIS Neurosciences News Small Pharma News Microbix Biosystems News IBEX Technologies News Aptose Biosciences News Covalon Technologies News Medicenna Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:IGX) was last updated on 5/30/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersWho are Nvidia’s New Silent Partners?Weiss RatingsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarBiden Nomination CANCELED?The Freeport SocietyDems have chosen Biden replacement?Paradigm Press[Urgent!] Generational Wealth GameplanCrypto 101 MediaShocking: One AI startup's revenue could surge 4,735%Manward PressDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin Pro Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IntelGenx Technologies Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
